Anti-DLL4 Reference Antibody (navicixizumab), Monoclonal

Produktübersicht

• Artikelname: Anti-DLL4 Reference Antibody (navicixizumab), Monoclonal
• Artikelnummer: SYB-CHA199
• Hersteller Artikelnummer: CHA199
• Alternativnummer: SYB-CHA199-100UG,SYB-CHA199-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics
• Spezies Reaktivität: Human

Produktbeschreibung

Anti-DLL4 Reference Antibody (navicixizumab)(CHA199) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• UniProt: Q9NR61
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: DLL4